International Business
- Share via
From Times Staff and Wire Reports
EC to Allow Squibb to Buy French Firm: The European Commission said it will allow U.S. pharmaceuticals firm Bristol Myers Squibb Co. to buy the 55% of French pharmaceuticals firm UPSA that it doesn’t already own. The commission, the executive body responsible for ensuring open competition in the 12-nation European Union, said the merger will not lead to Squibb gaining a dominant position in the medicines market.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
